NDC 68071-3587
cephalexin 250 mg per 5 mL for suspension
On the label: NuCare Pharmaceuticals.Inc.. It's repackaged: NuCare Pharmaceuticals.Inc. rebottles it from Lupin Pharmaceuticals, Inc.'s NDC 68180-441.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Lupin Limited | Mandideep, India | Makes it, makes the active ingredient and packages it | Serious problems, FDA actionNov 23, 2022 · 6 inspections, 3 with FDA action |
Repackaging site
- NuCare Pharmaceuticals,Inc., Orange, CA, United States · relabels it
Recalls
- Jan 9, 2019 · Class II · Lupin Pharmaceuticals Inc.
CGMP Deviations; presence of extraneous material in the was observed in area that is between the primary package that is heat sealed and secondary packaging (poly-woven bag) of sucrose (an excipient) used in the finished product.
Lots: lot F801282, Expiry June 2020
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Cephalexin: every company that makes it
- Form
- for suspension, oral
- Strength
- 250 mg per 5 mL
- Approval
- ANDA ANDA065234
- On the market since
- Sep 6, 2017
- Package NDCs
68071-3587-2- Official label
- DailyMed (National Library of Medicine), updated Mar 20, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?